We are live on ! Find out more
BC

Broadwater Capital Portfolio holdings

AUM $138M
1-Year Est. Return 28.86%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
+28.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$2.67M
Cap. Flow
-$4.06M
Cap. Flow %
-3.11%
Top 10 Hldgs %
45.58%
Holding
238
New
15
Increased
4
Reduced
39
Closed
3

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$30.3K
2
DGS icon
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
+$13.8K
3
GLD icon
SPDR Gold Trust
GLD
+$11.3K
4
SLV icon
iShares Silver Trust
SLV
+$10.3K
5
GDX icon
VanEck Gold Miners ETF
GDX
+$5.85K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$826K
2
AAPL icon
Apple
AAPL
+$751K
3
CVS icon
CVS Health
CVS
+$451K
4
IDXX icon
Idexx Laboratories
IDXX
+$444K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$120K

Sector Composition

Rank Sector Weight
1 Technology 28.18%
2 Healthcare 17.75%
3 Consumer Staples 13.5%
4 Communication Services 9.59%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADP icon
26
Automatic Data Processing
ADP
$109B
$1.46M 1.12%
5,845
– –
CVS icon
27
CVS Health
CVS
$135B
$1.34M 1.03%
16,776
-5,900
-26% -$451K
HON icon
28
Honeywell
HON
$76.4B
$1.33M 1.02%
6,878
-307
-4% -$57.8K
VZ icon
29
Verizon
VZ
$197B
$1.23M 0.95%
29,407
-2,300
-7% -$92.8K
IBM icon
30
IBM
IBM
$213B
$1.23M 0.95%
6,455
– –
ROP icon
31
Roper Technologies
ROP
$40.4B
$1.21M 0.93%
2,150
– –
XBI icon
32
State Street SPDR S&P Biotech ETF
XBI
$10B
$1.17M 0.9%
12,300
– –
O icon
33
Realty Income
O
$61.1B
$1.13M 0.87%
20,930
-530
-2% -$28.7K
FLO icon
34
Flowers Foods
FLO
$1.58B
$1.12M 0.86%
47,312
-2,300
-5% -$52.5K
NOC icon
35
Northrop Grumman
NOC
$76B
$1.12M 0.86%
2,340
– –
POR icon
36
Portland General Electric
POR
$5.82B
$1.11M 0.85%
26,364
-1,500
-5% -$61.8K
GD icon
37
General Dynamics
GD
$103B
$1.05M 0.81%
3,730
– –
PEP icon
38
PepsiCo
PEP
$196B
$1.04M 0.8%
5,930
-500
-8% -$84.2K
UNH icon
39
UnitedHealth
UNH
$382B
$868K 0.67%
1,754
– –
CL icon
40
Colgate-Palmolive
CL
$74.8B
$851K 0.65%
9,450
-650
-6% -$55.1K
BDX icon
41
Becton Dickinson
BDX
$46.4B
$835K 0.64%
3,373
– –
BMY icon
42
Bristol-Myers Squibb
BMY
$129B
$825K 0.63%
15,220
– –
SBUX icon
43
Starbucks
SBUX
$119B
$750K 0.58%
8,210
– –
AVY icon
44
Avery Dennison
AVY
$12.8B
$750K 0.58%
3,360
– –
QCOM icon
45
Qualcomm
QCOM
$164B
$715K 0.55%
4,223
– –
MMM icon
46
3M
MMM
$91.8B
$679K 0.52%
7,654
– –
PAYX icon
47
Paychex
PAYX
$43.4B
$678K 0.52%
5,520
– –
MPC icon
48
Marathon Petroleum
MPC
$90.1B
$675K 0.52%
3,350
– –
FAST icon
49
Fastenal
FAST
$54.8B
$617K 0.47%
16,000
– –
PFE icon
50
Pfizer
PFE
$143B
$584K 0.45%
21,032
– –
1
2
3 4 5

Similar funds

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
TC
Tannin Capital Charlotte, North Carolina $138M AUM
PBRA
Pine Brook Road Advisors Bedford, New York $138M AUM 19.16% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $138M AUM
LDNAM
Lepercq De Neuflize Asset Management New York $138M AUM 15.9% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
CI
Cria Inc New York $138M AUM
ACA
Arsenal Capital Advisors Conshohocken, Pennsylvania $138M AUM

Broadwater Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Broadwater Capital held 238 positions worth $130M, up 2.1% from $128M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Broadwater Capital withdrew a net $4.06M in Q1 2024, closing 3 positions and reducing 39 holdings. Its most notable exit was Idexx Laboratories, an estimated $444K position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Broadwater Capital opened a new position in Berkshire Hathaway Class B worth $32.4K.

  • Broadwater Capital's largest Q1 2024 buy was Berkshire Hathaway Class B: 77 shares worth $32.4K.
  • Broadwater Capital added most to Shell in Q1 2024, an estimated $1.86K increase.
  • Broadwater Capital's biggest Q1 2024 reduction was Microsoft, cutting an estimated $826K.
  • Broadwater Capital fully exited Idexx Laboratories in Q1 2024, selling an estimated $444K.
  • Broadwater Capital's ten largest holdings make up 46% of its $130M portfolio in Q1 2024.
  • Broadwater Capital opened 15 new positions and closed 3 in Q1 2024.
  • Broadwater Capital's portfolio value rose 2.1% quarter-over-quarter to $130M.

Based on Broadwater Capital's 13F filing for Q1 2024, filed 31 Oct 2025.